Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy

76Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Previous magnetic resonance spectroscopy (MRS) studies have shown that N-acetylaspartate (NAA) is reduced not only in the ipsilateral but also in the contralateral hippocampus of many patients with mesial temporal lobe epilepsy (mTLE). The reason for the contralateral damage is not dear. To test whether the hippocampus is also damaged if the focus is outside the hippocampus, we have measured patients with neocortical epilepsy (NE). Therefore, the goals of this study were to determine if hippocampal NAA is reduced in NE and if hippocampal NAA discriminates NE from mTLE. MRS imaging (MRSI) studies were performed on 10 NE patients and compared with MRSI results in 23 unilateral mTLE patients and 16 controls. The results show that, in contrast to mTLE, NAA was not reduced in the hippocampus of NE patients, neither ipsilateral nor contralateral to the seizure focus. These results suggest that repeated seizures do not cause secondary damage to the hippocampus. The absence of spectroscopic differences in NE may help to distinguish NE from mTLE.

Cite

CITATION STYLE

APA

Vermathen, P., Ende, G., Laxer, K. D., Knowlton, R. C., Matson, G. B., & Weiner, M. W. (1997). Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Annals of Neurology, 42(2), 194–199. https://doi.org/10.1002/ana.410420210

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free